(Reuters) - Halliburton Co said on Monday it will buy Baker Hughes Inc for about $35 billion in cash and stock, creating an oilfield services behemoth to take on market leader Schlumberger NV as customers curb spending on falling oil prices.
(Reuters) - Botox maker Allergan Inc on Monday accepted a $66 billion takeover bid from Actavis Plc, ending a seven-month hostile pursuit by activist investor William Ackman and Valeant Pharmaceuticals International Inc.
WASHINGTON (Reuters) - U.S. manufacturing output rose modestly in October as motor vehicle production fell for a third straight month, suggesting some slowing in economic growth at the start of the fourth quarter.
WASHINGTON (Reuters) - The Federal Reserve said it is hosting a meeting on Monday with banks and regulators to discuss the development of a reference rate alternative to LIBOR, the London interbank rate that was at the center of a global rigging scandal.
(Reuters) - The deadline to file claims under General Motors Co's faulty ignition-switch compensation program has been extended by one month to Jan. 31, said Kenneth Feinberg, the program's administrator.
ATLANTA (Reuters) - United Parcel Service Inc's chief executive officer said on Monday the company's closer collaboration with major retailers should bring a smooth holiday season, but he said UPS would charge customers more or even refuse packages if last-minute sales by a major customer threaten the company's system.
NEW YORK (Reuters) - Former customers of Bernard Madoff may soon recover an additional $496.8 million as a result of a settlement with two "feeder funds" that was announced on Monday by the trustee liquidating the swindler's firm.
NEW YORK (Reuters) - Takata Corp and Honda Motor Co were hit Monday with a lawsuit over an air bag linked to the death last month of a woman in Florida, the latest legal issue for the companies as they continue to recall millions of vehicles for the faulty part.
FRANKFURT/LONDON (Reuters) - Pfizer dampened investors' expectations of a renewed bid for AstraZeneca on Monday by signing a major cancer drug deal with Germany's Merck KGaA , reducing the U.S. firm's need for Astra's products.